Cavernous angioma other diagnostic studies

Jump to navigation Jump to search

Cavernous angioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Cavernous angioma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

CT

MRI

MRA

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cavernous angioma other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cavernous angioma other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cavernous angioma other diagnostic studies

CDC on Cavernous angioma other diagnostic studies

Cavernous angioma other diagnostic studies in the news

Blogs on Cavernous angioma other diagnostic studies

Directions to Hospitals Treating Cavernous angioma

Risk calculators and risk factors for Cavernous angioma other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.

Overview

Diagnostic biomarkers can be utilized too in conjunction with imaging tools to identify cavernous angioma.

Other Diagnostic Studies

Diagnostic biomarkers can be utilized too in conjunction with imaging tools to identify cavernous angioma.[1]

References

  1. Sone JY, Li Y, Hobson N, Romanos SG, Srinath A, Lyne SB; et al. (2021). "Perfusion and permeability as diagnostic biomarkers of cavernous angioma with symptomatic hemorrhage". J Cereb Blood Flow Metab. 41 (11): 2944–2956. doi:10.1177/0271678X211020587. PMC 8756480 Check |pmc= value (help). PMID 34039038 Check |pmid= value (help).